BioSpace News Archive

Drug Development

First Patient Dosing achieved in Mainland China in a Phase II Multi-regional clinical trial (MRCT)

I-Mab Biopharma today announced that the first patient in mainland China has been dosed in a phase II clinical trial of TJ301 for the treatment of ulcerative colitis (UC) at the Division of Gastroenterology, the First Affiliated Hospital of Sun Yat-sen University in Guangdong, China.

October 12, 2018
·
2 min read
Drug Development

MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013, a First-in-Class Biotherapeutic to Treat Acute GvHD

Microbiome restoration biological drug product to be tested for safety and overall survival impact in patients with acute Graft-versus-Host-Disease

October 12, 2018
·
4 min read
Deals

AmpliPhi Biosciences Announces Pricing of $6.6 Million Underwritten Public Offering

AmpliPhi Biosciences Corporation today announced the pricing of an underwritten public offering of 16,537,500 shares of its common stock

October 12, 2018
·
5 min read
Business

FIGS Becomes the First-Ever Medical Apparel Company to Open A Pop-Up Shop with Its First Location on Melrose Place

FIGS launches the first medical apparel pop-up shop ever in the luxury fashion district of Melrose Place, Los Angeles

October 12, 2018
·
3 min read
Policy

ThermoLife International, LLC Files Suit Against VPX, The Maker Of BANG Energy Drink, Alleging “Super Creatine” Is Not Actually Creatine, And That All BANG Energy Products Are Misbranded

On October 10, 2018, ThermoLife International, LLC filed suit in Arizona Federal District Court against Vital Pharmaceuticals, Inc. (“VPX”).

October 12, 2018
·
4 min read
Deals

Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation

Alliqua BioMedical, Inc. and Adynxx, Inc. today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the majority owners of Alliqua’s outstanding common stock on a fully-diluted basis.

October 12, 2018
·
12 min read
Business

Praxid, Natural Digestive And Heartburn Relief Multi-Supplement, Launches In The Market

Praxid, a natural daily multi-supplement to help relieve heartburn and promote digestive health, launched, providing a unique combination of clinically studied ingredients that provide a 360-degree approach to gut health.

October 12, 2018
·
3 min read
Policy

/R E P E A T -- Media Advisory - Mark Eyking, Member of Parliament for Sydney-Victoria, to participate in the Grand Opening of the Eskasoni Community Health Care Centre/

Please be advised that MP Eyking will attend the grand opening of the Eskasoni Health Care centre on behalf of the Honourable Jane Philpott, Minister of Indigenous Services.

October 12, 2018
·
1 min read
Triple-S Management Corporation’s Medicare Advantage HMO Offering Upgraded to 4.5 Star Rating

Triple-S Management Corporation (NYSE: GTS) (“Triple-S” or the “Company”), a leading managed care company in Puerto Rico, announced today that its 2019 Care Coordination Medicare Advantage HMO contract (H5774) has received an overall 4.5-star quality rating

October 12, 2018
·
5 min read
Job Trends

Industry Sees Strong Path Forward on Converting to non-Highly Enriched Uranium-based sources for Medical Imaging

Highly Enriched Uranium (HEU) is a nuclear substance that can be used to create a nuclear weapon. The Nuclear Threat Initiative has called HEU “one of the most dangerous materials on the planet."1

October 12, 2018
·
3 min read